Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ALTERITY THERAPEUTICS LTD (ATHE)
Standardized SEC financial data for ALTERITY THERAPEUTICS LTD — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001131343 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
52.0%
Return on equity
5.4%
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
A$
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
R&D expense
A$10.1M
A$12.3M
A$14.7M
A$13.2M
A$18.6M
A$14.4M
SG&A expense
A$3.4M
A$6.9M
A$5.5M
A$5.1M
A$4.8M
A$5.5M
Interest expense
A$4K
A$1K
A$2K
A$5K
A$7K
A$6K
Net income
-A$13.5M
-A$15.3M
-A$12.8M
-A$13.8M
-A$19.1M
-A$12.1M
Standardized from ALTERITY THERAPEUTICS LTD's SEC filings — per-share figures split-adjusted. Full history via the API.